期刊文献+

盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的疗效观察 被引量:18

Therapeutic effect of azelastine hydrochloride nasal spray combined with desloratadine in the treatment of allergic rhinitis
下载PDF
导出
摘要 目的探讨过敏性鼻炎采取盐酸氮卓斯汀鼻喷剂联合地氯雷他定的治疗效果。方法选择2014年6月至2016年6月本院收治的过敏性鼻炎80例患者,将患者随机分为联合组和喷剂组,各40例。联合组患者采取盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗,喷剂组患者采取盐酸氮卓斯汀鼻喷剂治疗,比较两组患者的治疗效果及安全性。结果联合组患者治疗总有效率为97.50%,明显高于喷剂组的80.00%,差异具有统计学意义(P<0.05)。联合组患者治疗后鼻涕、鼻痒、鼻塞、喷嚏症状评分均低于喷剂组,差异具有统计学意义(P<0.05)。联合组患者用药后不良反应总发生率略高于喷剂组,差异不具有统计学意义(P>0.05)。结论过敏性鼻炎采取盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗的效果显著,可有效改善患者的临床症状,且具有较高安全性,可进行临床推广。 Objective To explore the therapeutic effect of azelastine hydrochloride nasal spray combined with desloratadine in the treatment of allergic rhinitis. Methods Eighty cases of patients with allergic rhinitis from June 2014 to June 2016 in our hospital were selected and randomly divided into combined group and spray group, with 40 cases in each group. The combined group was treated with azelastine hydrochloride nasal spray combined with desloratadine, and the spray group was treated with azelastine hydrochloride nasal spray. The efficacy and safety of the two groups were compared.Results The total effective rate was 97.50% in the combined group, which was significantly higher than 80.00% in the spray group, the difference was statistically significant(P〈0.05). The scores of nasal, nasal itching, nasal obstruction and sneezing in the combined group were lower than those in the spray group(P〈0.05). The overall incidence of adverse reactions in the combined group was significantly higher than that in the spray group, but the difference was not statistically significant(P〉0.05). Conclusion Azelastine hydrochloride nasal spray combined with loratadine has significant treatment effect for allergic rhinitis. It can significantly improve the clinical symptoms of the patients and has high safety, which can be promoted in clinic.
作者 陈健
出处 《临床医学研究与实践》 2017年第20期23-24,共2页 Clinical Research and Practice
关键词 过敏性鼻炎 盐酸氮卓斯汀鼻喷剂 地氯雷他定 allergic rhinitis azelastine hydrochloride nasal spray desloratadine
  • 相关文献

参考文献10

二级参考文献56

  • 1顾之燕.盐酸氮斯汀鼻喷剂治疗变应性鼻炎[J].中华耳鼻咽喉头颈外科杂志,2005,40(9):717-720. 被引量:27
  • 2徐道华.第三代抗组胺药地氯雷他定[J].中国新药杂志,2005,14(12):1486-1488. 被引量:59
  • 3黄选兆,汪吉宝,孔雏佳,等.实用耳鼻咽喉科头颈外科学[M].北京:人民卫生出版社,2009.218-225.
  • 4Zhang L,Han D,Huang D,et al.Prevalence of self-reported allergic rhinitis in eleven major cities in china[J].Int Arch Allergy Immunol,2009,149(1):47.
  • 5Chaudhufi R,Livingston E,McMahon AD,et al.Cigarette smoking impaim the therapeutic response to oral corticosteroids in chronic asthma[J].Am J Respir Crit Care Med,2003,168:1308.
  • 6Lee CH, Jang JH, Lee HJ, et al. Clinical characteristics of aller- gic rhinitis according to allergic rhinitis and its impact on asthma guidelines [ J ]. Clin Exp Otorhinolaryngo|, 2008,1 (4) : 196 -200.
  • 7中华耳鼻喉科头颈外科杂志编辑委员会,中华医学会耳鼻喉科分会.过敏性鼻炎的治疗原则和推荐方案(2004年,兰州)[J].中华耳鼻喉科头颈外科杂志,2005,40(3):166-167.
  • 8Schroeder JT, Schleimer RP, Lichtenstein LM, et al. Inhibition of cytokine generation and mediator release by human basophils trea- ted with desloratadine [ J ]. Clin Exp Allergy, 2001,31 (9) : 1369-1377.
  • 9Roumestan C, Henriquel C ,Gougat C, et al. HistamineH1 receptor antagonists inhibit nucle AR factor kappa B and activator protein 1 activitiesvia H1 receptor dependent and independent mechanisms [J]. Clin Exp Allergy,2008,38(6) :947-956.
  • 10张萍,何荷,曹惠芳.等.联合氮卓斯汀鼻喷剂治疗支气管哮喘合并变应性鼻炎87例临床分析[J].中国医师进修杂志,2014,37(z1):77-79.

共引文献132

同被引文献112

引证文献18

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部